News and Events

UCL announces the launch of gene therapy company Athena Vision

Publication date:

Athena Vision logo

Athena Vision is focused on developing gene therapies for eye diseases based on research conducted at UCL.

UCL Business PLC, the wholly-owned technology transfer company of UCL, today announced the formation of Athena Vision Limited, a biopharmaceutical company focused on the development of gene therapies to treat a range of devastating eye diseases causing blindness.

Poorer dementia patients in England less likely to be prescribed drugs

Publication date:


Dementia patients from more affluent areas in England are 27% more likely to be prescribed anti-dementia drugs than patients from poorer areas, finds a new UCL study of 77,045 dementia patients across the UK. This inequality was not seen in Scotland, Northern Ireland or Wales.

Developing molecular diagnostics for pneumonia in hospitals

Publication date:


Clinicians and scientists from UCLH, UCL and the University of East Anglia (UEA) have been awarded a £2.5 million grant by the National Institute for Health Research to develop and evaluate new molecular diagnostic tests.

Changes in humour an early sign of dementia

Publication date:


Researchers at UCL have revealed that a change in sense of humour could be an early sign of dementia. The findings could help improve dementia diagnosis, by highlighting changes not commonly thought to be linked to the condition.

UCL professor is first UK winner of $3m Breakthrough Prize in Life Sciences

Publication date:

Professor John Hardy

Professor John Hardy (UCL Institute of Neurology) was last night awarded the $3 million Breakthrough Prize in Life Sciences for his pioneering research into the genetic causes of Alzheimer’s disease, other forms of dementia and Parkinson’s disease.

Search UCL News

Support us | Vacancies and fellowships | Contact SLMS | IT for SLMS